Welcome to our dedicated page for Red Violet SEC filings (Ticker: RDVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Red Violet, Inc. (NASDAQ: RDVT), a Delaware corporation based in Boca Raton, Florida. As a public company, Red Violet submits periodic and current reports that describe its financial condition, operating results, and significant corporate events related to its analytics and information solutions business.
Recent Form 8-K filings illustrate how Red Violet uses SEC reports to communicate with investors. For example, the company has filed current reports to furnish press releases announcing financial results for quarters ended June 30, 2025 and September 30, 2025, and to provide conference call transcripts as exhibits. Another Form 8-K details the Board of Directors’ approval of an increase to the authorization under the company’s stock repurchase program, including the total amount authorized and the remaining capacity.
In addition to 8-Ks, investors can review Red Violet’s annual reports on Form 10-K and other periodic filings for comprehensive information on revenue, expenses, cash flows, risk factors, and management’s discussion and analysis. The company’s disclosures also explain its use of non-GAAP financial measures such as adjusted EBITDA, adjusted net income, adjusted earnings per share, adjusted gross profit, adjusted gross margin, and free cash flow, along with reconciliations to the most directly comparable GAAP metrics.
On Stock Titan, these filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries help interpret lengthy documents by highlighting key topics such as quarterly performance, changes in capital allocation policies like repurchase programs, and commentary on the identity intelligence and analytics solutions that Red Violet provides. Users can also review insider and executive-related disclosures when they appear in the company’s filings, gaining additional context on governance and ownership.
Whether you are researching Red Violet’s financial history, examining the details behind an earnings release, or looking for the official text of a conference call transcript referenced in an 8-K, this page centralizes the company’s regulatory record with tools to make complex filings easier to understand.
Red Violet, Inc. (RDVT) reported insider activity: Chief Information Officer Jeffrey Dell sold a total of 10,000 shares of common stock across multiple trades from 11/10/2025 to 11/13/2025. The sales were executed in multiple transactions with weighted average prices ranging from $56.72 to $58.81, as detailed in footnotes.
Following these transactions, Dell beneficially owns 155,934 shares directly. This figure includes 20,000 RSUs granted on 11/30/2023 that vest in two equal installments on 12/1/2025 and 12/1/2026, and 15,750 RSUs granted on 11/4/2024 that vest in two equal installments on 11/1/2026 and 11/1/2027. The filing notes that each day’s sales were comprised of multiple trades within disclosed price ranges.
Red Violet (RDVT) reported insider activity by CEO and Chairman Derek Dubner. Between 11/10/2025 and 11/13/2025, he sold a total of 15,000 shares of common stock in seven open‑market transactions. Weighted average prices per tranche ranged from $56.73 to $58.81, with disclosed trade price ranges spanning $56.40 to $58.92.
Following these sales, his beneficial ownership was 556,000 shares, held directly. This figure includes 26,666 RSUs granted on November 30, 2023, scheduled to vest in equal parts on December 1, 2025 and December 1, 2026, and 21,000 RSUs granted on November 4, 2024, scheduled to vest in equal parts on November 1, 2026 and November 1, 2027.
Red Violet, Inc. (RDVT) CFO Daniel MacLachlan reported open‑market sales of common stock on 11/10–11/13/2025, as disclosed in a Form 4. Each day’s trades were executed in multiple transactions, with weighted average prices per share of $58.81 (11/10), $58.03 (11/10), $57.81 (11/11), $58.10 (11/12), $57.80 (11/12), $57.57 (11/13), and $56.73 (11/13). The transactions occurred within an overall price range of $56.40 to $58.92, as noted in the footnotes.
Following these reported sales, the table shows 358,163 shares beneficially owned after an 11/13/2025 transaction. The filing also notes 26,666 RSUs granted on 11/30/2023 vesting in two equal installments on December 1, 2025 and December 1, 2026, and 21,000 RSUs granted on 11/4/2024 vesting in two equal installments on November 1, 2026 and November 1, 2027, each convertible into common stock on a one‑for‑one basis.
Red Violet (RDVT) President James Reilly reported multiple open‑market sales of common stock. Tranches executed from November 10–13, 2025 included 733 shares at a weighted average price of $58.81; 6,273 at $58.03; 2,184 at $57.81; 651 at $58.10; 3,448 at $57.80; 445 at $57.57; and 1,266 at $56.73. Following these transactions, he beneficially owned 231,078 shares directly.
The reported holdings include 26,666 RSUs granted November 30, 2023 (vesting December 1, 2025 and December 1, 2026) and 21,000 RSUs granted November 4, 2024 (vesting November 1, 2026 and November 1, 2027).
Red Violet, Inc. furnished, under Regulation FD, a press release and a conference call transcript announcing financial results for the third quarter ended September 30, 2025. The company issued the materials on November 5, 2025 and provided the transcript as Exhibit 99.1.
The furnished information, including Exhibit 99.1, is not deemed “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless specifically stated. An Inline XBRL cover page (Exhibit 104) accompanies the filing.
Red Violet, Inc. (RDVT) reported strong Q3 performance. Revenue rose to $23.1 million, up 21% year over year, while net income increased to $4.2 million, up 145%. Diluted EPS was $0.29. Adjusted EBITDA reached $9.0 million with a 39% margin, reflecting operating leverage as gross margin improved to 73%.
Cash and cash equivalents were $45.4 million as of September 30, 2025. Operating cash flow for the quarter was $10.2 million, and for the nine months it was $22.7 million. The company paid a special cash dividend of $0.30 per share in February and repurchased 15,437 shares in Q3. The board expanded the stock repurchase authorization to $30.0 million, with $18.9 million remaining.
Customer metrics expanded: IDI billable customers reached 9,853 and FOREWARN users 372,209. The company disclosed total commitments of $44.9 million under data licensing and cloud agreements and noted an ongoing Daniel’s Law legal action in New Jersey; the insurer has been notified and coverage is anticipated, subject to limits.
Red Violet, Inc. (RDVT) expanded its stock repurchase capacity, approving an additional $15.0 million under its Stock Repurchase Program, bringing total authorization to $30.0 million. As of November 3, 2025, approximately $18.9 million remained available for repurchases.
The company also furnished a press release announcing financial results for the third quarter ended September 30, 2025. The release was provided as Exhibit 99.1 and is furnished, not filed, under the Exchange Act.
Red Violet, Inc. (RDVT) reported an insider transaction on a Form 4. The Chief Information Officer disposed of 7,034 shares of common stock on 11/03/2025 under transaction code F, indicating shares were withheld to satisfy tax obligations, at a price of $53.63.
Following the transaction, the insider beneficially owned 165,934 shares directly. The disposition was tied to the vesting of RSU tranches from awards approved on October 12, 2022 (third tranche of 10,000 RSUs) and November 4, 2024 (first tranche of 7,875 RSUs).
Outstanding RSUs include 20,000 granted on November 30, 2023, vesting in equal installments on December 1, 2025 and December 1, 2026, and 15,750 granted on November 4, 2024, vesting in equal installments on November 1, 2026 and November 1, 2027.
Red Violet, Inc. (RDVT) reported a Form 4 for CEO, Director, and Chairman Derek Dubner. On 11/03/2025, he reported a code F disposition of 9,379 common shares at $53.63 per share to satisfy tax obligations upon RSU vesting. Following the transaction, Dubner reported 571,000 shares beneficially owned, held directly.
Per the footnotes, the tax withholding relates to the vesting of the third tranche of 13,333 RSUs from a grant approved on October 12, 2022 and the first tranche of 10,500 RSUs from a grant approved on November 4, 2024. His holdings include 26,666 RSUs (granted November 30, 2023) vesting in equal parts on December 1, 2025 and December 1, 2026, and 21,000 RSUs (granted November 4, 2024) vesting in equal parts on November 1, 2026 and November 1, 2027, each convertible one-for-one into common stock and subject to accelerated vesting under certain circumstances.
Red Violet, Inc. (RDVT) reported an insider transaction by its Chief Financial Officer. On 11/03/2025, the officer disposed of 9,379 shares of common stock at $53.63 via a Code F transaction, which reflects shares withheld by the issuer to cover taxes upon RSU vesting. Following the transaction, the officer beneficially owns 373,163 shares directly and 466 shares indirectly through an IRA.
The tax withholding relates to vesting tranches from prior RSU grants, including a third tranche of 13,333 RSUs (approved 10/12/2022) and a first tranche of 10,500 RSUs (approved 11/04/2024). Footnotes also note 26,666 RSUs granted 11/30/2023 vesting on 12/01/2025 and 12/01/2026, and 21,000 RSUs granted 11/04/2024 vesting on 11/01/2026 and 11/01/2027.